COVID-19. Diseases of the respiratory system
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients who, have one / more of the following symptoms, in addition to acute respiratory illness (ARI):•RR> 30•PO2 <93% •Pulmonary infiltration in chest x-ray •Clinical judgment of a specialist physician 2- Age range of (18-75) years of both sexes 3- patient must not have any serious simultaneous heart, lung, brain and endocrine diseases 4- The patient's ability and personal desire to fill out a personal consent form to enter the study
Exclusion criteria
Exclusion criteria: Pregnancy and breastfeeding Existence of any history of allergy to Mentha longifolia and its products patient's Inability to consume the oral form existence of any condition that prevents the continuing of the therapeutic intervention based on the physician's judgment Patient intubation Nausea and vomiting Resistant hypoxemia loss of consciousness Hemodynamic instability
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction of hospitalization rate. Timepoint: Daily. Method of measurement: Patient record.;Respiratory rate. Timepoint: Daily. Method of measurement: By RR monitor or manual counting of breaths.;Oxygen saturation. Timepoint: 8 am and 8 pm. Method of measurement: Pulsoximeter. | — |
Secondary
| Measure | Time frame |
|---|---|
| Heart rate. Timepoint: twice a day. Method of measurement: By monitor or manually.;Blood pressure measurement. Timepoint: Daily. Method of measurement: Mercury sphygmomanometer. | — |
Countries
Iran (Islamic Republic of)
Contacts
Mazandaran University of Medical Sciences